Retraction Notice to "Effect of subcutaneous lidocaine-hydroxypropyl-β-cyclodextrin (HP-β-CD) on quality of life in patients with post-COVID condition: a 36-week observational interrupted time series study" [eClinicalMedicine 90(2025) 103681].
Where this comes from
- Record sourced from PubMed, PMID 41859675.
- Also identified by DOI 10.1016/j.eclinm.2026.103843 and PMC identifier 12996267.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This retracts the article DOI: 10.1016/j.eclinm.2025.103681.].